Prelude Therapeutics (PRLD) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Prelude Therapeutics

    NASDAQ: PRLD · Real-Time Price · USD
    1.47
    0.03 (2.08%)
    At close: Oct 03, 2025, 3:59 PM
    1.47
    0.00%
    After-hours: Oct 03, 2025, 04:10 PM EDT

    Prelude Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -127.17M -121.83M -115.44M -111.69M
    Depreciation & Amortization
    		 1.77M 1.17M 1.32M 915K
    Stock-Based Compensation
    		 21.34M 25.62M 25.14M 20.93M
    Other Working Capital
    		 911K -8.21M 1.28M -278K
    Other Non-Cash Items
    		 -3.05M -1.54M 4.31M 1.33M
    Deferred Income Tax
    		 n/a n/a n/a 1.36M
    Change in Working Capital
    		 4.22M -10.48M 932K 3.63M
    Operating Cash Flow
    		 -102.89M -107.06M -83.73M -83.53M
    Capital Expenditures
    		 -764K -3.51M -3.02M -2.32M
    Cash Acquisitions
    		 n/a n/a -84.71K n/a
    Purchase of Investments
    		 -52.69M -221.63M -119.22M -261.48M
    Sales Maturities Of Investments
    		 143.65M 190.5M 203.93M n/a
    Other Investing Acitivies
    		 n/a n/a 84.71K -261.48K
    Investing Cash Flow
    		 90.19M -34.65M 81.69M -263.8M
    Debt Repayment
    		 -395K n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 -54K 664K 815K 3.47M
    Financial Cash Flow
    		 -120K 136.4M 815K 164.9M
    Net Cash Flow
    		 -12.82M -5.31M -1.22M -182.44M
    Free Cash Flow
    		 -103.65M -110.58M -86.75M -85.85M

    Add to Watchlist